STTCOMP OCC TA LONG
Regenerative medicine company.
Mkt Cap - $87M
Cash on hand - $9M
Company has 3 regenerative products:
1. CelGro® Nerve Regeneration - in pre-clinical study process
2. CelGro® Tendon repair - has successful final trial results
3. CelGro® Bone and soft tissue repair - already commercialized and has some approvals. Right now generating some revenue and growing international product awareness and expanding regulatory approvals.
